Pathstone Holdings, LLC Guardant Health, Inc. Transaction History
Pathstone Holdings, LLC
- $22.2 Billion
- Q4 2024
A detailed history of Pathstone Holdings, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 7,174 shares of GH stock, worth $306,042. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,174Holding current value
$306,042% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$514 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$479 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$274 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$232 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$223 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.36B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...